The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Patient-defined goals and preferences among adults with advanced neuroendocrine tumors.
 
Daneng Li
Consulting or Advisory Role - Adagene; Advanced Accelerator Applications; Eisai; Exelixis; Genentech; Ipsen; Lexicon; Merck; MINA THERAPEUTICS; QED Therapeutics; Taiho Pharmaceutical; Tersera
Speakers' Bureau - Advanced Accelerator Applications; Coherus Biosciences; Eisai; Exelixis; Ipsen; Lexicon; Sun Pharma; Tersera
Research Funding - AstraZeneca (Inst); Brooklyn ImmunoTherapeutics (Inst)
 
Can-Lan Sun
Stock and Other Ownership Interests - FORMA THERAPEUTICS; Merck; Pfizer; Vertex
 
Heeyoung Kim
No Relationships to Disclose
 
Christiana Crook
No Relationships to Disclose
 
Ya-Han Zhang
No Relationships to Disclose
 
Rebecca Allen
No Relationships to Disclose
 
Richard Ballena
No Relationships to Disclose
 
Shadman Hyder
No Relationships to Disclose
 
Marianna Koczywas
Speakers' Bureau - AstraZeneca; Celgene
 
Vincent Chung
Consulting or Advisory Role - Apeiron Biologics; Gritstone Bio; Ipsen; Westwood Bioscience
Speakers' Bureau - Celgene; Ipsen
Research Funding - Merck (Inst); Roche (Inst)
 
Dean Lim
No Relationships to Disclose
 
Vani Katheria
No Relationships to Disclose
 
Arti Hurria
No Relationships to Disclose
 
William Dale
No Relationships to Disclose
 
Gagandeep Singh
Patents, Royalties, Other Intellectual Property - I have device patents, that are completely unrelated to the publication. We have not sold them to anybody or have any prospective buyers at this time. I have no money generated from them.
Expert Testimony - Kaiser Permanente